Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Pci Biotech AS
AS
Active
Org 982611830
Ullernchausséen 64, 0379
Oslo
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2000 · 25 years old
5 employees
www.pcibiotech.no
Monitor
Share
Norway
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Pci Biotech AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
9M
7M
4M
2M
0M
2020: 7M
7M
2020
2021: 6M (-14% vs 2020)
6M
-14%
2021
2022: 5M (-17% vs 2021)
5M
-17%
2022
2023: 3M (-40% vs 2022)
3M
-40%
2023
2024: 7M (+133% vs 2023)
7M
+133%
2024
EBITDA
NOK millions
0M
-25M
-50M
-76M
-101M
2020: -77M
-77M
2020
2021: -81M (-5% vs 2020)
-81M
-5%
2021
2022: -51M (+37% vs 2021)
-51M
+37%
2022
2023: -18M (+65% vs 2022)
-18M
+65%
2023
2024: -14M (+22% vs 2023)
-14M
+22%
2024
Income statement
NOK thousands
Item
2024
2023
2022
2021
2020
Revenue
6 735
2 990
4 750
6 273
7 368
Staff expenses
−0
−0
−0
−0
−0
EBITDA
−13 727
−17 605
−51 225
−81 060
−77 457
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−13 727
−17 605
−51 225
−81 060
−77 457
Net financials
1 361
1 404
−369
−1 233
−1 211
Profit before tax
−12 366
−16 201
−51 594
−82 293
−78 668
Tax
−0
−0
−0
−0
−0
Net profit
−12 366
−16 201
−51 594
−82 293
−78 668
Balance sheet
NOK thousands
Item
2024
2023
2022
2021
2020
Total assets
31 534
43 001
62 830
109 469
140 562
Equity
24 723
36 260
50 506
73 393
102 748
Long-term debt
0
34
327
1 277
32
Short-term debt
6 812
6 707
11 998
34 799
37 783
Total debt
6 812
6 741
12 325
36 076
37 815
Financial ratios
5-year trend
EBITDA margin
−203,8 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2020
2024
Equity ratio
78,4 %
This company
38,2 %
Market median
This company
Market median
105% above market
2020
2024
Return on equity
−50,0 %
This company
18,4 %
Market median
This company
Market median
372% below market
2020
2024
Net profit margin
−183,6 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2020
2024
Asset turnover
0,21×
This company
1,12×
Market median
This company
Market median
81% below market
2020
2024
Debt / equity
0,28×
This company
0,62×
Market median
This company
Market median
55% below market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
More on Pci Biotech AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
